Etiracetam is under investigation in clinical trial NCT01137110 (Comparison of Short Duration Levetiracetam to Extended Course for Seizure Prophylaxis After Subarachnoid Hemorrhage (SAH)).
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Etiracetam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Etiracetam. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Etiracetam. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Etiracetam. |
| Hydrocodone | Etiracetam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Etiracetam. |
| Magnesium sulfate | The therapeutic efficacy of Etiracetam can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Etiracetam may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Etiracetam may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Etiracetam. |
| Mirtazapine | Etiracetam may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Etiracetam. |
| Orphenadrine | Etiracetam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Etiracetam may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Etiracetam. |
| Pramipexole | Etiracetam may increase the sedative activities of Pramipexole. |
| Ropinirole | Etiracetam may increase the sedative activities of Ropinirole. |
| Rotigotine | Etiracetam may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Etiracetam. |
| Sodium oxybate | Etiracetam may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Etiracetam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Etiracetam. |
| Thalidomide | Etiracetam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Etiracetam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Mefloquine | The therapeutic efficacy of Etiracetam can be decreased when used in combination with Mefloquine. |
| Mianserin | The therapeutic efficacy of Etiracetam can be decreased when used in combination with Mianserin. |
| Orlistat | Orlistat can cause a decrease in the absorption of Etiracetam resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Topotecan | Etiracetam may increase the excretion rate of Topotecan which could result in a lower serum level and potentially a reduction in efficacy. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Etiracetam. |
| Tetracosactide | The risk or severity of liver damage can be increased when Tetracosactide is combined with Etiracetam. |
| Ethanol | Etiracetam may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Etiracetam may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Etiracetam. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Etiracetam is combined with Fluvoxamine. |
| Citalopram | The risk or severity of adverse effects can be increased when Etiracetam is combined with Citalopram. |
| Duloxetine | The risk or severity of adverse effects can be increased when Etiracetam is combined with Duloxetine. |
| Trazodone | The risk or severity of adverse effects can be increased when Etiracetam is combined with Trazodone. |
| Paroxetine | The risk or severity of adverse effects can be increased when Etiracetam is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Etiracetam is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Etiracetam is combined with Sibutramine. |
| Nefazodone | The risk or severity of adverse effects can be increased when Etiracetam is combined with Nefazodone. |
| Escitalopram | The risk or severity of adverse effects can be increased when Etiracetam is combined with Escitalopram. |
| Zimelidine | The risk or severity of adverse effects can be increased when Etiracetam is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Etiracetam is combined with Dapoxetine. |
| Milnacipran | The risk or severity of adverse effects can be increased when Etiracetam is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Etiracetam is combined with Desvenlafaxine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Etiracetam is combined with Seproxetine. |
| Indalpine | The risk or severity of adverse effects can be increased when Etiracetam is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Etiracetam is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Etiracetam is combined with Alaproclate. |
| Amitriptyline | The risk or severity of CNS depression can be increased when Amitriptyline is combined with Etiracetam. |
| Cyproheptadine | The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Etiracetam. |
| Imipramine | The risk or severity of CNS depression can be increased when Imipramine is combined with Etiracetam. |
| Nortriptyline | The risk or severity of CNS depression can be increased when Nortriptyline is combined with Etiracetam. |
| Amoxapine | The risk or severity of CNS depression can be increased when Amoxapine is combined with Etiracetam. |
| Propiomazine | The risk or severity of CNS depression can be increased when Propiomazine is combined with Etiracetam. |
| Cocaine | The risk or severity of methemoglobinemia can be increased when Etiracetam is combined with Cocaine. |
| Quinidine | The therapeutic efficacy of Etiracetam can be decreased when used in combination with Quinidine. |
| Maprotiline | The risk or severity of CNS depression can be increased when Maprotiline is combined with Etiracetam. |
| Doxepin | The risk or severity of CNS depression can be increased when Doxepin is combined with Etiracetam. |
| Desipramine | The risk or severity of CNS depression can be increased when Desipramine is combined with Etiracetam. |
| Pizotifen | The risk or severity of CNS depression can be increased when Pizotifen is combined with Etiracetam. |
| Dosulepin | The risk or severity of CNS depression can be increased when Dosulepin is combined with Etiracetam. |
| Zopiclone | The risk or severity of adverse effects can be increased when Etiracetam is combined with Zopiclone. |
| Botulinum toxin type B | The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Etiracetam. |
| Botulinum toxin type A | The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Etiracetam. |
| Tryptophan | The risk or severity of CNS depression can be increased when Tryptophan is combined with Etiracetam. |
| Baclofen | Baclofen may increase the central nervous system depressant (CNS depressant) activities of Etiracetam. |
| Lorazepam | The risk or severity of CNS depression can be increased when Lorazepam is combined with Etiracetam. |
| Ethchlorvynol | The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Etiracetam. |
| Succinylcholine | The risk or severity of CNS depression can be increased when Succinylcholine is combined with Etiracetam. |
| Reserpine | The risk or severity of CNS depression can be increased when Reserpine is combined with Etiracetam. |
| Eletriptan | The risk or severity of CNS depression can be increased when Eletriptan is combined with Etiracetam. |
| Enflurane | The risk or severity of CNS depression can be increased when Enflurane is combined with Etiracetam. |
| Temazepam | The risk or severity of CNS depression can be increased when Temazepam is combined with Etiracetam. |
| Reboxetine | The risk or severity of CNS depression can be increased when Reboxetine is combined with Etiracetam. |
| Butabarbital | The risk or severity of CNS depression can be increased when Butabarbital is combined with Etiracetam. |
| Butalbital | The risk or severity of CNS depression can be increased when Butalbital is combined with Etiracetam. |
| Methysergide | The risk or severity of CNS depression can be increased when Methysergide is combined with Etiracetam. |
| Cabergoline | The risk or severity of CNS depression can be increased when Cabergoline is combined with Etiracetam. |
| Phenytoin | The risk or severity of CNS depression can be increased when Phenytoin is combined with Etiracetam. |
| Topiramate | The risk or severity of CNS depression can be increased when Topiramate is combined with Etiracetam. |
| Clemastine | The risk or severity of CNS depression can be increased when Clemastine is combined with Etiracetam. |
| Venlafaxine | The risk or severity of CNS depression can be increased when Venlafaxine is combined with Etiracetam. |
| Etomidate | The risk or severity of CNS depression can be increased when Etomidate is combined with Etiracetam. |
| Morphine | The risk or severity of CNS depression can be increased when Morphine is combined with Etiracetam. |
| Talbutal | The risk or severity of CNS depression can be increased when Talbutal is combined with Etiracetam. |
| Pentobarbital | The risk or severity of CNS depression can be increased when Pentobarbital is combined with Etiracetam. |
| Valproic acid | The risk or severity of CNS depression can be increased when Valproic acid is combined with Etiracetam. |
| Zolmitriptan | The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Etiracetam. |
| Codeine | The risk or severity of CNS depression can be increased when Codeine is combined with Etiracetam. |
| Dihydroergotamine | The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Etiracetam. |
| Tolcapone | The risk or severity of CNS depression can be increased when Tolcapone is combined with Etiracetam. |
| Hydromorphone | The risk or severity of CNS depression can be increased when Hydromorphone is combined with Etiracetam. |
| Olanzapine | The risk or severity of CNS depression can be increased when Olanzapine is combined with Etiracetam. |
| Cetirizine | The risk or severity of CNS depression can be increased when Cetirizine is combined with Etiracetam. |
| Protriptyline | The risk or severity of CNS depression can be increased when Protriptyline is combined with Etiracetam. |
| Trimethadione | The risk or severity of CNS depression can be increased when Trimethadione is combined with Etiracetam. |
| Clobazam | The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Etiracetam. |
| Chlorzoxazone | The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Etiracetam. |